Black Creek trims PriceSmart after a strong run β conviction intactBlack Creek trims PriceSmart after a strong run β conviction intact
Elanco Animal Health Inc ELAN
$19.80
βΌ -0.65%
($-0.13)
Open
$19.78
Prev Close
$19.93
Day Range
$19.40 β $20.24
52W Range
$12.40 β $27.72
Market Cap
$9.89B
Beta
1.71
EPS (TTM)
$-0.51
π Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2018-09-20 |
| Shares Out. | 499,380,000 |
| Website | elanco.com/ β |
| Phone | 18773526261 |
Elanco Animal Health Inc is a publicly traded company under the ticker symbol ELAN on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
23 analysts (2026-05-01)
π° Latest News for ELAN
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
Elanco Launches Befrenaβ’ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
Elanco Animal Health Rolls Out Befrena Monoclonal Antibody To Treat Anine Allergic, Atopic Dermatitis
5 Insightful Analyst Questions From Elancoβs Q1 Earnings Call
Elanco to Participate in Upcoming Investor Conferences
Elanco Animal Health Q1 Earnings Call Highlights
Elanco Animal Health (ELAN) Is Up 20.1% After Raising 2026 Guidance On Innovation-Led Growth
